Holen Sie sich die Stockscreener-App
0.7485
6.00%
0.0424
Schlusskurs vom Vortag:
$0.7061
Offen:
$0.715
24-Stunden-Volumen:
3.62M
Relative Volume:
0.18
Marktkapitalisierung:
$54.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-33.36M
KGV:
-1.1162
EPS:
-0.6706
Netto-Cashflow:
$-23.09M
1W Leistung:
-6.10%
1M Leistung:
+253.07%
6M Leistung:
+17.87%
1J Leistung:
-26.62%
1-Tages-Spanne:
$0.709
$0.7502
1-Wochen-Bereich:
$0.7003
$0.7895
52-Wochen-Spanne:
$0.1952
$1.55
Pds Biotechnology Corp Stock (PDSB) Company Profile
Firmenname
Pds Biotechnology Corp
Sektor
Branche
Telefon
800-208-3343
Adresse
303A COLLEGE ROAD EAST, PRINCETON
Compare PDSB vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PDSB
Pds Biotechnology Corp
|
0.7485 | 57.77M | 0 | -33.36M | -23.09M | -0.6706 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Pds Biotechnology Corp Stock (PDSB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-01 | Eingeleitet | B. Riley Securities | Buy |
| 2021-06-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-05-27 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-03-09 | Eingeleitet | Noble Capital Markets | Outperform |
| 2019-10-24 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Pds Biotechnology Corp Aktie (PDSB) Neueste Nachrichten
Head and Neck Squamous Cell Carcinoma (HNSCC)Market Insights, Epidemiology, and Market Forecast - GlobeNewswire Inc.
Average basic shares outstanding of PDS Biotechnology Corp. – HAN:EU6 - TradingView
PDS Biotechnology Corporation (PDSB) Stock Price, News, Quote & History - Yahoo! Finance Canada
symbol__ Stock Quote Price and Forecast - cnn.com
PDS Biotechnology (NASDAQ: PDSB) Announces Phase 2 VERSATILE-002 Trial Results with 39.3-Month Median Survival - kalkinemedia.com
PDS Biotech reports 39.3-month survival data for HPV16 therapy By Investing.com - Investing.com Australia
PDS Biotech’s PDS0101 Shows 39.3-Month Median Survival in JAMA Oncology Publication - Minichart
PDS Biotech reports 39.3-month survival data for HPV16 therapy - Investing.com
PDS Biotech Announces Publication of VERSATILE-002 Phase 2 Clinical Trial Results of PDS0101 with pembrolizumab in HPV16-Positive Recurrent and/or Metastatic (R/M) Head and Neck Cancer in JAMA Oncology - The Manila Times
A head-and-neck cancer trial reported 39.3 months of median survival - Stock Titan
Patrick Soon-Shiong Secures Board Seat at PDS Biotechnology with 19.9% Stake - TradingView
PDS Biotechnology gets 19.9% Nant Capital stake | PDSB SEC FilingForm SCHEDULE 13D - Stock Titan
PDS Biotechnology updates corporate presentation highlighting PDS0301 clinical data and financing - TradingView
Patrick Soon-Shiong backs PDS Biotechnology (NASDAQ: PDSB) as cancer drugs move toward Phase 3 - Stock Titan
PDS Biotechnology Corporation (PDSB) Options ChainYahoo Finance - Yahoo! Finance Canada
PDS Biotechnology (PDSB) Stock Fair Value Moves Lower After Analyst Cuts And Financing Scrutiny - Yahoo Finance
PullBack Stocks PDSB, PRSO, IGC, RETO: Who Breaks First? - FinancialContent
PDS Biotech Stock Surges Tuesday: What's Driving the Action? - Benzinga
PDS Biotechnology jumps as investors react to PIPE closing and Patrick Soon-Shiong tie-up - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PDSB Financing Adds 40 Million Share Equivalents Before Warrants - TechStock²
PDS Biotechnology Closes $11.3 Million Initial PIPE Tranche Led by Nant Capital - Minichart
PDS Biotechnology Retires Debt and Secures New Financing - TipRanks
PDS Biotechnology Retires Yorkville $6M Note Early With $4.6M Redemption - TradingView
PDS Biotech Raises $11.3 Million in Initial PIPE Led by Patrick Soon-Shiong - citybiz
PDS Biotechnology Raises $11.3 Million in Initial Closing of PIPE Led by Nant Capital; Dr. Soon-Shiong Joins Board - Quiver Quantitative
Weekly Recap: Up to $22.55M PIPE and HC Wainwright cuts price target to $5 - TradingView
PDS Biotechnology Market Sentiment - Benzinga España
Most Active Stocks on September 8: PDS Biotech, Green Circle, Mobix Labs, Intel and Nokia Lead Volume - ChartMill
Curious about the most active stocks on Tuesday? - ChartMill
PDS Biotech soars as it announces up to $22.55 million financing - thepharmaletter.com
PDS Biotech Jumps as Soon-Shiong-Backed Financing Eases Funding Pressure - Quiver Quantitative
PDS Biotech raises up to USD 22.55m to advance IL-12 immunotherapy toward Phase III in CRC - AllSci
Dow Tumbles 450 Points; US Small Business Sentiment Declines In August - Benzinga
PDS Biotechnology Announces PIPE Financing and Strategic Alignment - TipRanks
PDS Biotech raises up to $22.55M led by Nant Capital - Investing.com Canada
Phase 3 trial plan could unlock $11M more for PDS Biotechnology (NASDAQ: PDSB) - Stock Titan
PDS Biotech Announces up to $22.55 Million Financing Led by Dr. Patrick Soon-Shiong, Founder of NantWorks - marketscreener.com
80% survived at least two years in a 22-patient trial of PDS Biotech's cancer treatment - Stock Titan
PDS Biotechnology’s Phase 3 Head and Neck Cancer Trial Termination: What It Means for Investors - TipRanks
PDS Biotech’s Lender Gets 100% of New Non-ATM Equity Cash - TechStock²
PDSB News | PDS BIOTECHNOLOGY CORP (NASDAQ:PDSB) - ChartMill
PDS Biotechnology Amends $6 Million Promissory Note, Tightening Repayment With YA II PN - TradingView
PDS Biotechnology (Nasdaq: PDSB) changes terms on a $6M loan - Stock Titan
Stephan Toutain removed as COO at PDS Biotechnology - TradingView
PDS Biotechnology (PDSB) to shed 36% of staff and part ways with COO - Stock Titan
PDS Biotechnology Corp (NASDAQ: PDSB) Share Price, PDSB Stock News, PDSB Share Price & Updates - Kalkine
Form 8K PDS Biotechnology Corp For: 19 August By Investing.com - Investing.com Nigeria
PDS Biotechnology announces CFO resignation and interim appointments - Investing.com
PDS Biotechnology CFO Lars Boesgaard to Resign; Janetta Trochimiuk and Frank Bedu-Addo Appointed Interim Officers - TradingView
PDS Biotechnology (NASDAQ: PDSB) CEO takes interim finance role as CFO departs - Stock Titan
Finanzdaten der Pds Biotechnology Corp-Aktie (PDSB)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):